thiamorpholine has been researched along with acenaphthenequinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Feng, Y; Li, X; Liu, C; Qin, J; Song, T; Wu, Z; Xie, F; Zhang, Z | 1 |
1 other study(ies) available for thiamorpholine and acenaphthenequinone
| Article | Year |
|---|---|
Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach.
Topics: Acrylonitrile; Benzylamines; Binding Sites; Biomimetics; Blotting, Western; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Solubility; Structure-Activity Relationship; Thermodynamics | 2013 |